Channel Therapeutics Corp (CHRO) FinancialsCHROChannel Therapeutics Corp

In the context of the broader market, CHRO competes directly with industry leaders such as CODX and APVO. With a market capitalization of N/A, it holds a significant position in the sector. When comparing efficiency, CHRO's gross margin of N/A stands against CODX's -48.76% and APVO's N/A. Such benchmarking helps identify whether Channel Therapeutics Corp is trading at a premium or discount relative to its financial performance.